These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25093529)

  • 21. ISIS 2302. INXC ICAM1, Oligo-TCS.
    Drugs R D; 1999 Jan; 1(1):85-6. PubMed ID: 10565996
    [No Abstract]   [Full Text] [Related]  

  • 22. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys.
    Henry SP; Bolte H; Auletta C; Kornbrust DJ
    Toxicology; 1997 Jun; 120(2):145-55. PubMed ID: 9184201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
    Baker PJ; Adler S; Yang Y; Couser WG
    J Immunol; 1984 Aug; 133(2):877-81. PubMed ID: 6376629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects.
    Mangsbo SM; Sanchez J; Anger K; Lambris JD; Ekdahl KN; Loskog AS; Nilsson B; Tötterman TH
    J Immunol; 2009 Nov; 183(10):6724-32. PubMed ID: 19864604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys.
    Burel SA; Han SR; Lee HS; Norris DA; Lee BS; Machemer T; Park SY; Zhou T; He G; Kim Y; MacLeod AR; Monia BP; Lio S; Kim TW; Henry SP
    Nucleic Acid Ther; 2013 Jun; 23(3):213-27. PubMed ID: 23692080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey.
    Galbraith WM; Hobson WC; Giclas PC; Schechter PJ; Agrawal S
    Antisense Res Dev; 1994; 4(3):201-6. PubMed ID: 7849490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2'-MOE-Modified Antisense Oligonucleotide.
    Narayanan P; Shen L; Curtis BR; Bourdon MA; Nolan JP; Gupta S; Hoffmaster C; Zhou F; Christian B; Schaubhut JL; Greenlee S; Burel SA; Witztum JL; Engelhardt JA; Henry SP
    Toxicol Sci; 2018 Aug; 164(2):613-626. PubMed ID: 29846725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new approach to preparation of antisense oligonucleotide samples with microextraction by packed sorbent.
    Nuckowski Ł; Kaczmarkiewicz A; Studzińska S; Buszewski B
    Analyst; 2019 Aug; 144(15):4622-4632. PubMed ID: 31245798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys.
    Yu RZ; Gunawan R; Post N; Zanardi T; Hall S; Burkey J; Kim TW; Graham MJ; Prakash TP; Seth PP; Swayze EE; Geary RS; Henry SP; Wang Y
    Nucleic Acid Ther; 2016 Dec; 26(6):372-380. PubMed ID: 27500733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISIS 2302. Oligo-TCS.
    Drugs R D; 1999 Mar; 1(3):265-7. PubMed ID: 10566042
    [No Abstract]   [Full Text] [Related]  

  • 38. Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.
    Renner B; Ferreira VP; Cortes C; Goldberg R; Ljubanovic D; Pangburn MK; Pickering MC; Tomlinson S; Holland-Neidermyer A; Strassheim D; Holers VM; Thurman JM
    Kidney Int; 2011 Jul; 80(2):165-73. PubMed ID: 21544060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein.
    Fujita T; Fujioka T; Murakami T; Satomura A; Fuke Y; Matsumoto K
    J Clin Lab Anal; 2007; 21(1):14-23. PubMed ID: 17245758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.
    Moghimi SM; Hunter AC; Dadswell CM; Savay S; Alving CR; Szebeni J
    Biochim Biophys Acta; 2004 Jun; 1689(2):103-13. PubMed ID: 15196591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.